Global Stem Cells Market Analysis and Forecast 2024-2030

Global Stem Cells Market Analysis and Forecast 2024-2030


Summary

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).

According to APO Research, The global Stem Cells market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Stem Cells include Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi-post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen and Takeda (TiGenix), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Stem Cells, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Stem Cells, also provides the revenue of main regions and countries. Of the upcoming market potential for Stem Cells, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Stem Cells revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Stem Cells market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Stem Cells revenue, projected growth trends, production technology, application and end-user industry.

Stem Cells segment by Company

Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
Medi-post
JCR Pharmaceutical
MolMed
Pharmicell
Anterogen
Takeda (TiGenix)
CBR
ViaCord
Esperite
LifeCell
CCBC
VCANBIO
BOYA LIFE
Beike Biotechnology
International Medical
Stem Cells segment by Type

Stem Cell Storage
Stem Cell Pharmaceutical and Treatment
Stem Cells segment by Application

Diseases of the Central Nervous System
Cardiovascular Disease
Diabetes
Cancer
Genetic Diseases
Autoimmune Disease
Bone and Cartilage Repair
Other
Stem Cells segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Stem Cells in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Stem Cells company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Stem Cells revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Stem Cells Market by Type
1.2.1 Global Stem Cells Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Stem Cell Storage
1.2.3 Stem Cell Pharmaceutical and Treatment
1.3 Stem Cells Market by Application
1.3.1 Global Stem Cells Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Diseases of the Central Nervous System
1.3.3 Cardiovascular Disease
1.3.4 Diabetes
1.3.5 Cancer
1.3.6 Genetic Diseases
1.3.7 Autoimmune Disease
1.3.8 Bone and Cartilage Repair
1.3.9 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Stem Cells Market Dynamics
2.1 Stem Cells Industry Trends
2.2 Stem Cells Industry Drivers
2.3 Stem Cells Industry Opportunities and Challenges
2.4 Stem Cells Industry Restraints
3 Global Growth Perspective
3.1 Global Stem Cells Market Perspective (2019-2030)
3.2 Global Stem Cells Growth Trends by Region
3.2.1 Global Stem Cells Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Stem Cells Market Size by Region (2019-2024)
3.2.3 Global Stem Cells Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Stem Cells Revenue by Players
4.1.1 Global Stem Cells Revenue by Players (2019-2024)
4.1.2 Global Stem Cells Revenue Market Share by Players (2019-2024)
4.1.3 Global Stem Cells Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Stem Cells Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Stem Cells Key Players Headquarters & Area Served
4.4 Global Stem Cells Players, Product Type & Application
4.5 Global Stem Cells Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Stem Cells Market CR5 and HHI
4.6.2 Global Top 5 and 10 Stem Cells Players Market Share by Revenue in 2023
4.6.3 2023 Stem Cells Tier 1, Tier 2, and Tier 3
5 Stem Cells Market Size by Type
5.1 Global Stem Cells Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Stem Cells Revenue by Type (2019-2030)
5.3 Global Stem Cells Revenue Market Share by Type (2019-2030)
6 Stem Cells Market Size by Application
6.1 Global Stem Cells Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Stem Cells Revenue by Application (2019-2030)
6.3 Global Stem Cells Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Osiris Therapeutics
7.1.1 Osiris Therapeutics Comapny Information
7.1.2 Osiris Therapeutics Business Overview
7.1.3 Osiris Therapeutics Stem Cells Revenue and Gross Margin (2019-2024)
7.1.4 Osiris Therapeutics Stem Cells Product Portfolio
7.1.5 Osiris Therapeutics Recent Developments
7.2 NuVasive
7.2.1 NuVasive Comapny Information
7.2.2 NuVasive Business Overview
7.2.3 NuVasive Stem Cells Revenue and Gross Margin (2019-2024)
7.2.4 NuVasive Stem Cells Product Portfolio
7.2.5 NuVasive Recent Developments
7.3 Chiesi Pharmaceuticals
7.3.1 Chiesi Pharmaceuticals Comapny Information
7.3.2 Chiesi Pharmaceuticals Business Overview
7.3.3 Chiesi Pharmaceuticals Stem Cells Revenue and Gross Margin (2019-2024)
7.3.4 Chiesi Pharmaceuticals Stem Cells Product Portfolio
7.3.5 Chiesi Pharmaceuticals Recent Developments
7.4 Medi-post
7.4.1 Medi-post Comapny Information
7.4.2 Medi-post Business Overview
7.4.3 Medi-post Stem Cells Revenue and Gross Margin (2019-2024)
7.4.4 Medi-post Stem Cells Product Portfolio
7.4.5 Medi-post Recent Developments
7.5 JCR Pharmaceutical
7.5.1 JCR Pharmaceutical Comapny Information
7.5.2 JCR Pharmaceutical Business Overview
7.5.3 JCR Pharmaceutical Stem Cells Revenue and Gross Margin (2019-2024)
7.5.4 JCR Pharmaceutical Stem Cells Product Portfolio
7.5.5 JCR Pharmaceutical Recent Developments
7.6 MolMed
7.6.1 MolMed Comapny Information
7.6.2 MolMed Business Overview
7.6.3 MolMed Stem Cells Revenue and Gross Margin (2019-2024)
7.6.4 MolMed Stem Cells Product Portfolio
7.6.5 MolMed Recent Developments
7.7 Pharmicell
7.7.1 Pharmicell Comapny Information
7.7.2 Pharmicell Business Overview
7.7.3 Pharmicell Stem Cells Revenue and Gross Margin (2019-2024)
7.7.4 Pharmicell Stem Cells Product Portfolio
7.7.5 Pharmicell Recent Developments
7.8 Anterogen
7.8.1 Anterogen Comapny Information
7.8.2 Anterogen Business Overview
7.8.3 Anterogen Stem Cells Revenue and Gross Margin (2019-2024)
7.8.4 Anterogen Stem Cells Product Portfolio
7.8.5 Anterogen Recent Developments
7.9 Takeda (TiGenix)
7.9.1 Takeda (TiGenix) Comapny Information
7.9.2 Takeda (TiGenix) Business Overview
7.9.3 Takeda (TiGenix) Stem Cells Revenue and Gross Margin (2019-2024)
7.9.4 Takeda (TiGenix) Stem Cells Product Portfolio
7.9.5 Takeda (TiGenix) Recent Developments
7.10 CBR
7.10.1 CBR Comapny Information
7.10.2 CBR Business Overview
7.10.3 CBR Stem Cells Revenue and Gross Margin (2019-2024)
7.10.4 CBR Stem Cells Product Portfolio
7.10.5 CBR Recent Developments
7.11 ViaCord
7.11.1 ViaCord Comapny Information
7.11.2 ViaCord Business Overview
7.11.3 ViaCord Stem Cells Revenue and Gross Margin (2019-2024)
7.11.4 ViaCord Stem Cells Product Portfolio
7.11.5 ViaCord Recent Developments
7.12 Esperite
7.12.1 Esperite Comapny Information
7.12.2 Esperite Business Overview
7.12.3 Esperite Stem Cells Revenue and Gross Margin (2019-2024)
7.12.4 Esperite Stem Cells Product Portfolio
7.12.5 Esperite Recent Developments
7.13 LifeCell
7.13.1 LifeCell Comapny Information
7.13.2 LifeCell Business Overview
7.13.3 LifeCell Stem Cells Revenue and Gross Margin (2019-2024)
7.13.4 LifeCell Stem Cells Product Portfolio
7.13.5 LifeCell Recent Developments
7.14 CCBC
7.14.1 CCBC Comapny Information
7.14.2 CCBC Business Overview
7.14.3 CCBC Stem Cells Revenue and Gross Margin (2019-2024)
7.14.4 CCBC Stem Cells Product Portfolio
7.14.5 CCBC Recent Developments
7.15 VCANBIO
7.15.1 VCANBIO Comapny Information
7.15.2 VCANBIO Business Overview
7.15.3 VCANBIO Stem Cells Revenue and Gross Margin (2019-2024)
7.15.4 VCANBIO Stem Cells Product Portfolio
7.15.5 VCANBIO Recent Developments
7.16 BOYA LIFE
7.16.1 BOYA LIFE Comapny Information
7.16.2 BOYA LIFE Business Overview
7.16.3 BOYA LIFE Stem Cells Revenue and Gross Margin (2019-2024)
7.16.4 BOYA LIFE Stem Cells Product Portfolio
7.16.5 BOYA LIFE Recent Developments
7.17 Beike Biotechnology
7.17.1 Beike Biotechnology Comapny Information
7.17.2 Beike Biotechnology Business Overview
7.17.3 Beike Biotechnology Stem Cells Revenue and Gross Margin (2019-2024)
7.17.4 Beike Biotechnology Stem Cells Product Portfolio
7.17.5 Beike Biotechnology Recent Developments
7.18 International Medical
7.18.1 International Medical Comapny Information
7.18.2 International Medical Business Overview
7.18.3 International Medical Stem Cells Revenue and Gross Margin (2019-2024)
7.18.4 International Medical Stem Cells Product Portfolio
7.18.5 International Medical Recent Developments
8 North America
8.1 North America Stem Cells Revenue (2019-2030)
8.2 North America Stem Cells Revenue by Type (2019-2030)
8.2.1 North America Stem Cells Revenue by Type (2019-2024)
8.2.2 North America Stem Cells Revenue by Type (2025-2030)
8.3 North America Stem Cells Revenue Share by Type (2019-2030)
8.4 North America Stem Cells Revenue by Application (2019-2030)
8.4.1 North America Stem Cells Revenue by Application (2019-2024)
8.4.2 North America Stem Cells Revenue by Application (2025-2030)
8.5 North America Stem Cells Revenue Share by Application (2019-2030)
8.6 North America Stem Cells Revenue by Country
8.6.1 North America Stem Cells Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Stem Cells Revenue by Country (2019-2024)
8.6.3 North America Stem Cells Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 Europe
9.1 Europe Stem Cells Revenue (2019-2030)
9.2 Europe Stem Cells Revenue by Type (2019-2030)
9.2.1 Europe Stem Cells Revenue by Type (2019-2024)
9.2.2 Europe Stem Cells Revenue by Type (2025-2030)
9.3 Europe Stem Cells Revenue Share by Type (2019-2030)
9.4 Europe Stem Cells Revenue by Application (2019-2030)
9.4.1 Europe Stem Cells Revenue by Application (2019-2024)
9.4.2 Europe Stem Cells Revenue by Application (2025-2030)
9.5 Europe Stem Cells Revenue Share by Application (2019-2030)
9.6 Europe Stem Cells Revenue by Country
9.6.1 Europe Stem Cells Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Stem Cells Revenue by Country (2019-2024)
9.6.3 Europe Stem Cells Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Stem Cells Revenue (2019-2030)
10.2 China Stem Cells Revenue by Type (2019-2030)
10.2.1 China Stem Cells Revenue by Type (2019-2024)
10.2.2 China Stem Cells Revenue by Type (2025-2030)
10.3 China Stem Cells Revenue Share by Type (2019-2030)
10.4 China Stem Cells Revenue by Application (2019-2030)
10.4.1 China Stem Cells Revenue by Application (2019-2024)
10.4.2 China Stem Cells Revenue by Application (2025-2030)
10.5 China Stem Cells Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Stem Cells Revenue (2019-2030)
11.2 Asia Stem Cells Revenue by Type (2019-2030)
11.2.1 Asia Stem Cells Revenue by Type (2019-2024)
11.2.2 Asia Stem Cells Revenue by Type (2025-2030)
11.3 Asia Stem Cells Revenue Share by Type (2019-2030)
11.4 Asia Stem Cells Revenue by Application (2019-2030)
11.4.1 Asia Stem Cells Revenue by Application (2019-2024)
11.4.2 Asia Stem Cells Revenue by Application (2025-2030)
11.5 Asia Stem Cells Revenue Share by Application (2019-2030)
11.6 Asia Stem Cells Revenue by Country
11.6.1 Asia Stem Cells Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Stem Cells Revenue by Country (2019-2024)
11.6.3 Asia Stem Cells Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Stem Cells Revenue (2019-2030)
12.2 MEALA Stem Cells Revenue by Type (2019-2030)
12.2.1 MEALA Stem Cells Revenue by Type (2019-2024)
12.2.2 MEALA Stem Cells Revenue by Type (2025-2030)
12.3 MEALA Stem Cells Revenue Share by Type (2019-2030)
12.4 MEALA Stem Cells Revenue by Application (2019-2030)
12.4.1 MEALA Stem Cells Revenue by Application (2019-2024)
12.4.2 MEALA Stem Cells Revenue by Application (2025-2030)
12.5 MEALA Stem Cells Revenue Share by Application (2019-2030)
12.6 MEALA Stem Cells Revenue by Country
12.6.1 MEALA Stem Cells Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Stem Cells Revenue by Country (2019-2024)
12.6.3 MEALA Stem Cells Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings